Sensulin LLC

Developing once-a-day glucose-reaponsive insulin. Giving Type I/II diabetes patients a chance at a normal life.

[Sensulin LLC @Sensulin]

Point of View: Oklahoma's $48 billion miracle, and a solid prescription for growth https://t.co/8xTemNjqUI via @newsok

[World Economic Forum @wef]

7 ways the ‘biological century’ will transform #healthcare https://t.co/byJ8r2XpyQ #innovation

[AngelMD @angelMD_Inc]

Last night we hosted a #syndicate event for @Sensulin and heard from CEO @mikemoradi on their development of a glucose-response insulin for Type I & II Diabetes, which may eliminate the need for multiple injections a day. Interested in learning more? https://t.co/SIT4JkWXNG

[AngelMD @angelMD_Inc]

The latest AngelMD newsletter has your chance to invest in @WindpactInc, @Sensulin, and more - https://t.co/wSMPf9ISRg

[AngelMD @angelMD_Inc]

Thanks to all who attended our Dallas event for @Sensulin and Beta Cat Pharma and a special thanks to Drs. Fred Duffy and Wendy Whittington for hosting! For more info on investing with AngelMD, visit https://t.co/7zpfCwqFEl

[Insperity @Insperity]

Be sure to catch this inspiring interview with Mike Moradi, Co-founder and CEO of @Sensulin a biotechnology company developing a next-generation insulin for type 1 and type 2 diabetes patients. https://t.co/jvzcpbVjFJ #healthcare

[Joseph N Macaluso MD FACS @MacalusoJoseph]

@angelMD_Inc @HWildCatters @DFWTechEvents @CTANAngels @nextcoastVP @Houston_Angels @Alamo_Angels @Sensulin @mikemoradi @tjarthur @aggieangelnet @StartupAggies @AccelerateTexas @texashalofund @VentureBeat https://t.co/Xdttc5Jbh8

[Sensulin LLC @Sensulin]

Learn about our AngelMD Syndicate in Dallas! https://t.co/9AwvULnuv4

[Sensulin LLC @Sensulin]

Learn about our AngelMD Syndicate in Dallas! https://t.co/9AwvULnuv4

[Joseph N Macaluso MD FACS @MacalusoJoseph]

@mikemoradi CEO of @Sensulin speaking at #Alpha18 by @angelMD_Inc on their solution for the innovative treatment of #diabetes @Merck @sanofi @pfizer @LillyPad @AstraZeneca @AmDiabetesAssn @IntDiabetesFed @DiabetesUK @chinahealthnews @WSJTech @AbbottNews @abbvie

[Joseph N Macaluso MD FACS @MacalusoJoseph]

Charlie Emley Director of the Catalyst Fund from @angelMD_Inc during #Alpha18 presenting investment in @Sensulin to CEO @mikemoradi
@VentureBeat @ftchina @WSJTech @GEHealthcare @AmDiabetesAssn @AmerMedicalAssn @ahahospitals @tjarthur @MariaBartiromo @Forbes @NYTHealth

[World Economic Forum @wef]

This is what life will be like in 2030 https://t.co/s9IAoG51Q9

[Sensulin LLC @Sensulin]

6 Bold Predictions for Life in 2030: Our CEO @mikemoradi's @WEF Agenda article https://t.co/14EFLMEk0l

[Sensulin LLC @Sensulin]

#Sensulin CEO @mikemoradi featured on @businessinsider, alongside US YGLs @YGLvoices https://t.co/B8O9VlFLSV

[Sensulin LLC @Sensulin]

@Sensulin CEO & diabetes advocate @mikemoradi joins the #NEJM Visualizing Disease panel at #WEF #AMNC17 "Summer Davos." https://t.co/xEqvkmQhgz

[Grin News @grin_news]

How @mikemoradi and his @Sensulin plans to disrupt the world of #diabetes cure. https://t.co/o2kohfwAj0 #health #medicine

[Fannin Innovation Studio @FanninStudio]

@FanninStudio's Dev Chatterjee and @pulmotect's Nestor Molfino at a panel discussion at the US China Innovation and Investment Summit #UCIS

[World Economic Forum @Davos]

Live now: How new technologies could help prevent and manage epidemics https://t.co/fAyHhAfZaN #amnc17 @JeffDrazen @mikemoradi

[Sensulin LLC @Sensulin]

Meet #wef's 2017 Class of Young Global Leaders @ https://t.co/c4RyuL7rFi @YGLvoices #ygl17, incl. entrepreneur/diabetes advocate @mikemoradi

[TEDMED @TEDMED]

Congrats @mikemoradi of 2013 #TEDMED Hive org @Sensulin for making the 2017 Young Global Leaders class! @YGLvoices https://t.co/Rg9bxEXw6F